Chinese search giant Baidu is in discussions with investors to raise up to $2 billion over three years for a new biotech company, a person close to the matter told CNBC.The biotech company will try to use artificial intelligence and computing to develop drugs and and make early-stage diagnoses of diseases such as cancer, the person said.
The company would be a standalone entity rather than a subsidiary of Baidu, said a person close to the matter. The individual was not authorized to speak publicly about the project. A number of investors are interested in joining the funding, the person said, adding that they could not disclose more details as talks are still in the early stage.The biotech company would focus on using artificial intelligence and computing to create new drugs and and make early-stage diagnoses of diseases such as cancer, the person said.
百毒不侵
莆田生物（科技）
Sucker who invests, will be delisted from US markets soon
What is its competitive advantage on biotech? McDonalds may know better because of beef.
Why do we care?
State owned, nothing is owned in China w out CCPs behind the scenes ownership
Россия Последние новости, Россия Последние новости
Similar News:Вы также можете прочитать подобные новости, которые мы собрали из других источников новостей
Источник: BusinessInsider - 🏆 729. / 51 Прочитайте больше »